Endocrine Today Current Issue
The following articles appeared in the print edition of Endocrine Today.
Table of Contents
- Hospitals work to improve inpatient diabetes management
-
- Pharmacologic options boost weight loss
- Tired of low testosterone: Record check reveals cause of weight gain and fatigue Ronald Tamler, MD, PhD, MBA
- Peers can be part of the diabetes treatment team for teens Janet H. Silverstein, MD
- ‘The worst headache of my life’ Stephanie L. Lee, MD, PhD, ECNU; Elizabeth Herman, MD
- Biological variations influence ease of weight loss in obesity
- Boys with idiopathic short stature more likely to receive GH than girls
- DDT exposure in utero increases risk for breast cancer in adulthood
- Increase in overweight, obese population over past 20 years
-
- Intensive glycemic control reduces risk for major CV events, not mortality
- Vitamin D, calcium supplements fail to improve menopausal symptoms
- Bone ultrasound better predictor of fracture risk in patients with type 2 diabetes
- CDEs add effective diabetes management to primary care
- Dysglycemic extremes affect different brain regions in adolescents with type 1 diabetes
- EXAMINE: Use of Nesina, placebo with, without ACE inhibitors reveals similar CV outcomes
- GLP-1 receptor agonists change how brain responds to food
- Glycemic variability trial sets stage to study effects on diabetes complications
-
- High-intensity statin use low in patients with diabetes, high CVD risk
- Increased risk for cancer not found with Onglyza
- Lyxumia trial shows neutral CV risk in adults with type 2 diabetes, high risk for CVD
- New AACE obesity module, tool kit stress importance of patient-centered practices
- No additional threat of heart failure with Januvia in high-risk adults with type 2 diabetes
- Pamidronate preserves renal function, improves mortality in chronic critical illness
- Retinopathy common in pregnant Hispanic women with pre-existing diabetes
- Web-based program aids adults with prediabetes in lowering glycemic markers
-